HonCode

Go Back   HER2 Support Group Forums > Articles of Interest
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Reply
 
Thread Tools Display Modes
Old 04-16-2004, 01:37 AM   #1
Paul
Guest
 
Posts: n/a
A gene known to promote longevity in animals has now been discovered to encode a tumor suppressor – a protein that helps prevent cancer according to a study by a team of scientists from The University of Texas M. D. Anderson Cancer Center. The new gene which was inactivated in two-thirds of patients studied presents a potent new target for breast cancer therapy the researchers say.

In a study published in the April 16 2004 issue of the journal Cell scientists describe how the presence of the protein named Forkhead box class O3 (FOXO3) is associated with better outcomes for breast cancer patients. Conversely if FOXO3 was inactivated patients had worse outcomes.

The research team which was a collaboration between the laboratories of Mickey C.-T. Hu Ph.D. and Hung both of the Department of Molecular and Cellular Oncology at M. D. Anderson demonstrated that FOXO3 is inactivated in many cancer patients by an enzyme called IKK and determined that IKK is an oncoprotein a protein that can induce cancer.

The IKK oncoprotein belongs to a family of enzymes called kinases. Researchers have shown that blocking certain kinases can be an effective way to block cancer. New generation cancer drugs such as Gleevec which has been effective in treating leukemia patients work by zeroing in and inactivating a kinase molecule. Such targeted therapies are designed to kill cancer cells while avoiding serious damage to other non-cancerous cells.

The scientists discovered the protein’s role in cancer while studying how normal cells can turn cancerous. They showed that IKK can attach to the FOXO3 protein and inactivate it. When the normal function of FOXO3 is blocked the cell can multiply unchecked.

Once they had established that inactivated FOXO3 protein could lead to cancer the researchers examined its role in tumor cells from 131 breast cancer patients. They found FOXO3 in 113 out of 131 samples. Of the 113 samples with FOXO3 the protein was inactive in 83 and active in 30 samples. When they looked at patient survival they found a strong correlation between active FOXO3 and better patient survival. Additional research revealed the FOXO3 protein can be found in patients with stomach liver and lung cancer. However the scientists did not study enough of these patient samples to say how important the gene is in these cancers.

In additional laboratory studies the scientists demonstrated that a slightly altered form of FOXO3 that can’t be inactivated by IKK acts as an even more potent tumor suppressor than the normal FOXO protein.


  Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On

Forum Jump


All times are GMT -7. The time now is 09:42 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter